關鍵數據
0.553今開
0.638最高
19.96K成交量
虧損本益比TTM
--本益比動
--股利TTM
0.18%換手率
0.551昨收
0.520最低
6.94K成交額
虧損本益比靜
0.59市淨率
0.00%股息率 TTM
-31.47%ROA
3.51052週最高
0.24量比
-6.65M淨利潤
11.18M總股本
-1.0701每股盈餘TTM
--Beta
-42.99%ROE
0.38752週最低
21.42%振幅
-707.96%毛利率
5.82M總市值
-0.34回報/風險
14.36%風險率
Gelteq Ltd新聞
即將為您帶來更多新聞,敬請期待。 。 。
技術指標
財務指標
每股收益

由於公司未披露,未能獲取相關數據
營業總收入

由於公司未披露,未能獲取相關數據
Gelteq Ltd簡介
Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
公司代碼GELS
公司Gelteq Ltd
CEOGivoni (Nathan Jacob)
網址https://www.gelteq.com
公司股東
常見問題
Gelteq Ltd(GELS)的當前股價是多少?
Gelteq Ltd(GELS)的當前股價是 0.52。
Gelteq Ltd股票的52週最高點是3.51。
Gelteq Ltd股票的52週最低點是0.39。
Gelteq Ltd(GELS)股票的每股收益(EPS TTM)是多少
Gelteq Ltd(GELS)股票的每股收益(EPS TTM)是-0.46。